Acute Liver Failure with Portal Hypertension Management

Diagnosis and Initial Management

• The American Association for the Study of Liver Diseases recommends obtaining comprehensive liver function tests, including total bilirubin, AST, ALT, alkaline phosphatase, GGT, platelet count, prothrombin time/INR, and albumin to assess the severity of hepatic dysfunction in patients with acute liver failure with portal hypertension 1, 4
• The American College of Gastroenterology suggests performing immediate evaluation for specific treatable causes, including viral hepatitis serologies, autoimmune markers, Wilson disease screening, alpha-1 antitrypsin level and phenotype, and serum tryptase level to evaluate for systemic mastocytosis 1, 4, 5
• The National Comprehensive Cancer Network recommends considering liver transplantation for significant liver failure after excluding malignancy in patients with Budd-Chiari syndrome 1

Differential Diagnosis and Disease-Specific Management

• The American Association for the Study of Liver Diseases recommends considering Wilson disease in patients with acute liver failure, even over 40 years old, as cases have been confirmed into the 8th decade, and initiating chelation therapy with penicillamine or trientine if confirmed 4
• The Journal of the National Comprehensive Cancer Network suggests requiring cytoreductive therapy for systemic mastocytosis with C-findings and considering allogeneic hematopoietic cell transplantation for aggressive disease 2, 3

Monitoring and Complications

• The American College of Gastroenterology recommends monitoring for acute complications, including hepatic encephalopathy, variceal bleeding, splenic rupture risk, acute renal failure, and coagulopathy requiring fresh frozen plasma/cryoprecipitate in patients with acute liver failure with portal hypertension 4
• The National Comprehensive Cancer Network suggests serial laboratory monitoring every 6-12 hours initially, including liver function tests, INR, lactate, ammonia, complete blood count for cytopenias, and renal function 1, 2, 4

Transplant Evaluation

• The American Association for the Study of Liver Diseases recommends immediate transplant center consultation for fulminant hepatic failure with encephalopathy, progressive coagulopathy despite vitamin K, Budd-Chiari with significant liver failure, and Wilson disease with fulminant presentation 1, 4